Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | GLS | O94925 | 7/20 | 0.34 |
| ▸ | SAT1 | P21673 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6302961 | 0.82 | ALDH1A1 (0.38) | TDP1POLBKMT2AKDM4ECYP1A2 | |
| SCHEMBL6302334 | 0.81 | ALDH1A1 (0.37) | TDP1POLBKMT2AKDM4ECYP1A2 | |
| SCHEMBL6302536 | 0.81 | SAT1 (0.37) | TDP1KMT2ASAT1KDM4ECYP1A2 | |
| SCHEMBL6305461 | 0.81 | KMT2A (0.46) | TDP1POLBKMT2AKDM4E | |
| SCHEMBL6309368 | 0.81 | KMT2A (0.44) | TDP1POLBKMT2AKDM4E | |
| SCHEMBL6302919 | 0.79 | SCN1A (0.36) | TDP1POLBKMT2AKDM4ECYP1A2 | |
| SCHEMBL6305074 | 0.78 | KMT2A (0.38) | TDP1POLBKMT2AKDM4ECYP1A2 | |
| SCHEMBL2827007 | 0.77 | POLB (0.37) | TDP1POLBKMT2AOPRM1KDM4C | |
| SCHEMBL6305041 | 0.76 | KDM4C (0.36) | TDP1POLBKMT2AKDM4ECYP1A2 | |
| SCHEMBL6309307 | 0.76 | CYP1A2 (0.36) | TDP1POLBKMT2AKDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6949562-B2 | Heterocyclic compounds as ligands of the GABAA receptor | NEUROGEN CORPORATION (US) | 2005-09-27 | — | — | US | disclosed |